Shareholders Equity: The sum of preferred and common equity items.
ImageneBio, Inc. (IMA) had Shareholders Equity of $123.33M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.62M |
|
-- |
|
-- |
|
$12.08M |
|
$-12.08M |
|
$1.47M |
|
$-10.61M |
|
$-10.61M |
|
$-10.62M |
|
$-10.62M |
|
$-10.62M |
|
$-10.62M |
|
$-12.08M |
|
$-11.91M |
|
11.21M |
|
11.21M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$122.01M |
|
-- |
|
$14.68M |
|
$136.68M |
|
$6.63M |
|
-- |
|
$6.72M |
|
$13.36M |
|
$123.33M |
|
$123.33M |
|
|
Shareholders Equity |
$123.33M |
11.28M |
|
| Cash Flow Statement Financials | |
$-14.80M |
|
$-0.44M |
|
$-3.24M |
|
$94.53M |
|
$76.05M |
|
$-18.48M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.61% |
|
-8.61% |
|
-7.77% |
|
-8.61% |
|
$10.93 |
|
$-1.32 |
|
$-1.32 |
|